A phase I/II clinical trial with cell therapy treatment to significantly reduce the need for immune suppression treatment for both donor-matched and mismatched bone marrow transplant patients

Trial Profile

A phase I/II clinical trial with cell therapy treatment to significantly reduce the need for immune suppression treatment for both donor-matched and mismatched bone marrow transplant patients

Planning
Phase of Trial: Phase I/II

Latest Information Update: 11 Nov 2015

At a glance

  • Drugs Stem cell therapies (Primary)
  • Indications Bone marrow transplant rejection; Engraftment
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 11 Nov 2015 According to a company media release, Cell Source expects to use the same treatment protocol in this study that was used in the initial study conducted by the University of Parma (see CT profile 700263936).
    • 12 Aug 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top